Guangxi issues quality and efficacy consistency evaluation program of generic drugs

Source: Nanguo Morning Post Author: Zhang Ruofan 2017-1-3 recently, the general office of the government of Guangxi autonomous region printed and distributed the implementation plan of Guangxi to promote the quality and efficacy consistency evaluation of generic drugs (hereinafter referred to as the plan), making Guangxi become the province with earlier formulation of generic drug consistency evaluation plan in China When it comes to generic drugs, many people feel strange In fact, quite a part of the drugs people usually take are generic drugs Generic drugs are relative to the original drugs The original research drug refers to the original and independently developed new drug produced by the enterprise with drug patent right, which is often expensive The generic drugs are not original, but copy the main components of the original drugs After the expiration of the original research drug protection period, other countries and pharmaceutical factories can produce generic drugs Through the consistency evaluation, we can ensure that the generic drugs and the original drugs have the same active ingredients, dosage forms, routes of administration and therapeutic effects, so that the effectiveness and safety of the common people's drugs can be guaranteed It is understood that generic drugs can replace the original drugs in clinical practice, which can not only save medical costs, but also improve the quality of generic drugs and the overall level of the pharmaceutical industry According to the plan, by the end of 2018, the consistency evaluation of 74 generic drugs in Guangxi Autonomous Region will be completed, and the consistency evaluation must be completed by the end of 2021 for the varieties that need to carry out clinical effectiveness tests and have special circumstances Guangxi health and Family Planning Commission, development and Reform Commission, Department of science and technology, Department of finance, Department of human resources and social security and other relevant departments will actively arrange funds and projects to support the relevant enterprises of key participating varieties in the region to carry out technological transformation For drugs that pass the consistency evaluation, human resources and social security departments at all levels in Guangxi Autonomous Region will give appropriate support in the payment of medical insurance, and medical institutions will give priority to purchase and clinical use of drugs If there are more than three pharmaceutical manufacturers that have passed the consistency evaluation of the same kind of drugs, the ones that have failed the consistency evaluation will no longer be selected for centralized purchase of drugs.